REGENXBIO Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $4.6M | $221.4M | $54.1M |
| FY2016 | $11.0M | $172.7M | $24.8M |
| FY2017 | $15.6M | $198.7M | $46.7M |
| FY2018 | $35.0M | $543.8M | $75.6M |
| FY2019 | $47.7M | $497.9M | $69.5M |
| FY2020 | $330.4M | $708.2M | $338.4M |
| FY2021 | $349.6M | $1.11B | $345.2M |
| FY2022 | $317.1M | $833.3M | $97.0M |
| FY2023 | $262.2M | $574.0M | $34.5M |
| FY2024 | $206.3M | $466.0M | $57.5M |